drugset / Trial / NCT01673724
Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether pramipexole and bromocriptine are effective in the treatment of non-motor symptoms in Parkinson's Disease.
Timeline
- Start
- 2012-02
- Primary completion
- 2016-05-23
- Completion
- 2016-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bromocriptine | Small molecule | — | — |
| Subject | Pramipexole | Unknown | 0.125 mg | — |
| Subject | Pramipexole | Unknown | 0.25 mg | — |
| Subject | Pramipexole | Unknown | 0.5 mg | — |
| Subject | Pramipexole | Unknown | 1 mg | — |